|
Quotes & Info
|
| CRXX > SEC Filings for CRXX > Form 8-K on 21-Oct-2009 | All Recent SEC Filings |
21-Oct-2009
Other Events, Financial Statements and Exhibits
On October 21, 2009, CombinatoRx, Incorporated ("CombinatoRx") issued a press release announcing the results of a 12 month knee osteoarthritis (OA) Phase 2 extension trial for SynaviveTM (CRx-102). The full text of CombinatoRx's press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
(d) Exhibits
Exhibit No. Description
99.1 Press release of CombinatoRx, Incorporated dated October 21, 2009.
|
|